243 related articles for article (PubMed ID: 9765320)
21. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test.
Lamberti C; Ipponi A; Bartolini A; Schunack W; Malmberg-Aiello P
Br J Pharmacol; 1998 Apr; 123(7):1331-6. PubMed ID: 9579727
[TBL] [Abstract][Full Text] [Related]
23. The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.
Bolser DC; Blythin DJ; Chapman RW; Egan RW; Hey JA; Rizzo C; Kuo SC; Kreutner W
J Pharmacol Exp Ther; 1995 Sep; 274(3):1393-8. PubMed ID: 7562513
[TBL] [Abstract][Full Text] [Related]
24. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
25. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
[TBL] [Abstract][Full Text] [Related]
26. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
Nakaya M; Fukushima Y; Takeuchi N; Kaga K
Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
[TBL] [Abstract][Full Text] [Related]
28. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
[TBL] [Abstract][Full Text] [Related]
29. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of R-alpha-methylhistamine, a selective histamine H3 receptor agonist, in rats: lack of involvement of histamine H3 receptors.
Hegde SS; Chan P; Eglen RM
Eur J Pharmacol; 1994 Jan; 251(1):43-51. PubMed ID: 7907986
[TBL] [Abstract][Full Text] [Related]
31. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
[TBL] [Abstract][Full Text] [Related]
32. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.
Pérez-García C; Morales L; Cano MV; Sancho I; Alguacil LF
Psychopharmacology (Berl); 1999 Feb; 142(2):215-20. PubMed ID: 10102775
[TBL] [Abstract][Full Text] [Related]
33. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
[TBL] [Abstract][Full Text] [Related]
34. Trans-4-methyl-3-imidazoyl pyrrolidine as a potent, highly selective histamine H3 receptor agonist in vivo.
Shih NY; Aslanian R; Lupo AT; Orlando S; Piwinski JJ; Green MJ; Ganguly AK; West R; Tozzi S; Kreutner W; Hey JA
Bioorg Med Chem Lett; 1998 Feb; 8(3):243-8. PubMed ID: 9871662
[TBL] [Abstract][Full Text] [Related]
35. Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions.
Brabant C; Alleva L; Grisar T; Quertemont E; Lakaye B; Ohtsu H; Lin JS; Jatlow P; Picciotto MR; Tirelli E
Psychopharmacology (Berl); 2009 Mar; 202(4):673-87. PubMed ID: 18843481
[TBL] [Abstract][Full Text] [Related]
36. Substance P is involved in the effect of histamine H3 receptor agonist, Sch 50971 on nasal allergic symptoms in mice.
Yokota E; Kuyama S; Ogawa M; Kamei C
Int Immunopharmacol; 2008 Aug; 8(8):1083-8. PubMed ID: 18550011
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic profile of activation of histamine H3 receptors by R-alpha-methylhistamine in the guinea pig.
McLeod RL; Gertner SB; Hey JA
Gen Pharmacol; 1996 Sep; 27(6):1001-7. PubMed ID: 8909982
[TBL] [Abstract][Full Text] [Related]
38. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
[TBL] [Abstract][Full Text] [Related]
39. [The effect of central histamine H3 receptor on breathing activity of asthmatic guinea pigs].
Dong R; Zhang M; Lu BS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):117-21. PubMed ID: 21186598
[TBL] [Abstract][Full Text] [Related]
40. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
Krause M; Ligneau X; Stark H; Garbarg M; Schwartz JC; Schunack W
J Med Chem; 1998 Oct; 41(21):4171-6. PubMed ID: 9767653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
